person · Reporting owner
McGinnis Christopher A
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Express Scripts Holding Co.ESRX · Entity 161583 | VP, Controller & Ch. Acct. Off | March 08, 2017 | March 10, 2017 |
| GoodRx Holdings, Inc.GDRX · Entity 4838 | See Remarks | July 15, 2026 | July 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Express Scripts Holding Co.
Report date March 08, 2017 · Filed March 10, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,675 |
Reported balance
After 2017-03-08 transaction · row 1
1 source rowRow 1 · 2017-03-08 · Grant · Acquired 3,947 · Balance 6,675 F1: Grant of restricted stock units pursuant to Express Scripts Holding Company 2016 Long-Term Incentive Plan. Awards vest in three equal installments on February 28, 2018, February 28, 2019, and February 28, 2020. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock units pursuant to Express Scripts Holding Company 2016 Long-Term Incentive Plan. Awards vest in three equal installments on February 28, 2018, February 28, 2019, and February 28, 2020.
GoodRx Holdings, Inc.
Report date July 15, 2026 · Filed July 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 198,310 |
Ending reported balance
After 2026-07-15 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-07-15 · Exercise / conversion · Acquired 36,988 · Balance 214,604 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Row 2 · 2026-07-15 · Tax withholding · Disposed 16,294 · Balance 198,310 |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 369,877 |
Reported balance
After 2026-07-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-07-15 · Exercise / conversion · Disposed 36,988 · Balance 369,877 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2: The restricted stock units will vest ratably in 12 equal quarterly installments, with the first vesting occurring on April 15, 2026, and subject to continued service through each applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F2: The restricted stock units will vest ratably in 12 equal quarterly installments, with the first vesting occurring on April 15, 2026, and subject to continued service through each applicable vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 15, 2026 Filed Jul 16, 2026 20:26 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 36,988 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-26-000138 · wk-form4_1784233582.xml · derivative · entry 3 McGinnis Christopher A · CIK 0001652479 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 369,877 Underlying: Class A Common Stock · 36,988 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units will vest ratably in 12 equal quarterly installments, with the first vesting occurring on April 15, 2026, and subject to continued service through each applicable vesting date. F2 · derivative.expiration_date: The restricted stock units will vest ratably in 12 equal quarterly installments, with the first vesting occurring on April 15, 2026, and subject to continued service through each applicable vesting date. Read SEC document |
| July 15, 2026 Filed Jul 16, 2026 20:26 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 16,294 | $3.01 | $49,044.94 |
DisclosureSEC source: 0001809519-26-000138 · wk-form4_1784233582.xml · nonDerivative · entry 2 McGinnis Christopher A · CIK 0001652479 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198,310 Read SEC document |
| July 15, 2026 Filed Jul 16, 2026 20:26 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 36,988 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-26-000138 · wk-form4_1784233582.xml · nonDerivative · entry 1 McGinnis Christopher A · CIK 0001652479 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 214,604 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| May 15, 2026 Filed May 15, 2026 20:50 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 44,779 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-26-000114 · wk-form4_1778878209.xml · derivative · entry 3 McGinnis Christopher A · CIK 0001652479 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 492,580 Underlying: Class A Common Stock · 44,779 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award will vest as to 25% of the underlying shares on February 15, 2026 with the remaining 75% to vest in approximately equal quarterly installments thereafter for 12 quarters. F2 · derivative.expiration_date: The restricted stock unit award will vest as to 25% of the underlying shares on February 15, 2026 with the remaining 75% to vest in approximately equal quarterly installments thereafter for 12 quarters. Read SEC document |
| May 15, 2026 Filed May 15, 2026 20:50 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 19,726 | $2.49 | $49,117.74 |
DisclosureSEC source: 0001809519-26-000114 · wk-form4_1778878209.xml · nonDerivative · entry 2 McGinnis Christopher A · CIK 0001652479 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 177,616 Read SEC document |
| May 15, 2026 Filed May 15, 2026 20:50 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 44,779 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-26-000114 · wk-form4_1778878209.xml · nonDerivative · entry 1 McGinnis Christopher A · CIK 0001652479 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 197,342 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| April 15, 2026 Filed Apr 15, 2026 21:54 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 36,987 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-26-000075 · wk-form4_1776290078.xml · derivative · entry 3 McGinnis Christopher A · CIK 0001652479 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 406,865 Underlying: Class A Common Stock · 36,987 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units will vest ratably in 12 equal quarterly installments, with the first vesting occurring on April 15, 2026, and subject to continued service through each applicable vesting date. F2 · derivative.expiration_date: The restricted stock units will vest ratably in 12 equal quarterly installments, with the first vesting occurring on April 15, 2026, and subject to continued service through each applicable vesting date. Read SEC document |
| April 15, 2026 Filed Apr 15, 2026 21:54 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 10,745 | $2.23 | $23,961.35 |
DisclosureSEC source: 0001809519-26-000075 · wk-form4_1776290078.xml · nonDerivative · entry 2 McGinnis Christopher A · CIK 0001652479 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152,563 Read SEC document |
| April 15, 2026 Filed Apr 15, 2026 21:54 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantClass A Common Stock | 36,987 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-26-000075 · wk-form4_1776290078.xml · nonDerivative · entry 1 McGinnis Christopher A · CIK 0001652479 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 163,308 F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| March 03, 2026 Filed Mar 6, 2026 01:11 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantRestricted Stock Unit · Derivative | 443,852 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-26-000048 · wk-form4_1772759513.xml · derivative · entry 2 McGinnis Christopher A · CIK 0001652479 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 443,852 Underlying: Class A Common Stock · 443,852 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units will vest ratably in 12 equal quarterly installments, with the first vesting occurring on April 15, 2026, and subject to continued service through each applicable vesting date. F2 · derivative.expiration_date: The restricted stock units will vest ratably in 12 equal quarterly installments, with the first vesting occurring on April 15, 2026, and subject to continued service through each applicable vesting date. Read SEC document |
| February 15, 2026 Filed Feb 17, 2026 22:26 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 179,120 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-26-000014 · wk-form4_1771367162.xml · derivative · entry 3 McGinnis Christopher A · CIK 0001652479 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 537,359 Underlying: Class A Common Stock · 179,120 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award will vest as to 25% of the underlying shares on February 15, 2026 with the remaining 75% to vest in approximately equal quarterly installments thereafter for 12 quarters. F2 · derivative.expiration_date: The restricted stock unit award will vest as to 25% of the underlying shares on February 15, 2026 with the remaining 75% to vest in approximately equal quarterly installments thereafter for 12 quarters. Read SEC document |
| February 15, 2026 Filed Feb 17, 2026 22:26 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 52,799 | $2.18 | $115,101.82 |
DisclosureSEC source: 0001809519-26-000014 · wk-form4_1771367162.xml · nonDerivative · entry 2 McGinnis Christopher A · CIK 0001652479 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,321 Read SEC document |
| February 15, 2026 Filed Feb 17, 2026 22:26 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 179,120 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-26-000014 · wk-form4_1771367162.xml · nonDerivative · entry 1 McGinnis Christopher A · CIK 0001652479 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 179,120 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:47 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantStock Option (Right to Buy) · Derivative | 1,096,937 | $0.00 Strike: $4.85 | $0.00 |
DisclosureSEC source: 0001809519-25-000046 · wk-form4_1741214861.xml · derivative · entry 2 McGinnis Christopher A · CIK 0001652479 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,096,937 Underlying: Class A Common Stock · 1,096,937 shares Expires 2035-03-03 F3 · derivative.exercise_date: The option will vest and become exercisable as to 25% of the underlying shares on February 15, 2026 with the remaining 75% underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:47 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantRestricted Stock Unit · Derivative | 716,479 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000046 · wk-form4_1741214861.xml · derivative · entry 1 McGinnis Christopher A · CIK 0001652479 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 716,479 Underlying: Class A Common Stock · 716,479 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award will vest as to 25% of the underlying shares on February 15, 2026 with the remaining 75% underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters. F2 · derivative.expiration_date: The restricted stock unit award will vest as to 25% of the underlying shares on February 15, 2026 with the remaining 75% underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters. Read SEC document |
| March 08, 2017 Filed Mar 10, 2017 16:05 UTC | Express Scripts Holding Co. ESRX · Entity 161583 | GrantCommon Stock | 3,947 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-17-000308 · edgar.xml · nonDerivative · entry 1 McGinnis Christopher A · CIK 0001652479 · VP, Controller & Ch. Acct. Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,675 F1 · price: Grant of restricted stock units pursuant to Express Scripts Holding Company 2016 Long-Term Incentive Plan. Awards vest in three equal installments on February 28, 2018, February 28, 2019, and February 28, 2020. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 17:01 UTC | Express Scripts Holding Co. ESRX · Entity 161583 | Tax withholdingCommon Stock | 442 | $70.65 | $31,227.30 |
DisclosureSEC source: 0000950138-17-000250 · edgar.xml · nonDerivative · entry 1 McGinnis Christopher A · CIK 0001652479 · VP, Controller & Ch. Acct. Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,728 F1 · shares: Represents shares tendered to Company to cover Reporting Person's tax liability due upon vesting of restricted stock units previously awarded under long-term incentive plans. Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 16:51 UTC | Express Scripts Holding Co. ESRX · Entity 161583 | SaleCommon Stock | 1,785 | $70.77 | $126,324.45 |
DisclosureSEC source: 0000950138-16-001289 · edgar.xml · nonDerivative · entry 2 McGinnis Christopher A · CIK 0001652479 · VP, Controller & Ch. Acct. Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,170 F2 · shares: The sale transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| September 09, 2016 Filed Sep 13, 2016 16:51 UTC | Express Scripts Holding Co. ESRX · Entity 161583 | Tax withholdingCommon Stock | 974 | $71.13 | $69,280.62 |
DisclosureSEC source: 0000950138-16-001289 · edgar.xml · nonDerivative · entry 1 McGinnis Christopher A · CIK 0001652479 · VP, Controller & Ch. Acct. Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,955 F1 · shares: Represents shares tendered to Company to cover Reporting Person's tax liability due upon vesting of restricted stock units previously awarded under long-term incentive plans. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.